Erectile dysfunction is associated to cardiovascular disease

The risk of future cardiovascular disease and death increases with the severity of erectile dysfunction in men with and without a history of cardiovascular disease, according to a study published in ‘Plos Medicine’. Severe erectile dysfunction directly correlates with increased risk of cardiovascular disease and hospitalization for all cause mortality.

Men with no known history of cardiovascular disease that present serious rates of erectile dysfunction compared to men presenting no such rates saw a 35% increase of hospitalization risk for cardiovascular disease and a 93 % of all cause mortality risk. 

These results call for the need to acknowledge erectile dysfunction is associated with a large array of cardiovascular diseases. It also draws attention to the fact that it is highly unlikely erectile dysfunction causes cardiovascular disease; what happens is that they both have similar etiology, such as arteriosclerosis, which indicates erectile dysfunction could serve as a useful marker to identify men that should undergo additional testing to assess their risk to develop a cardiovascular condition. 

Source

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...